47 related articles for article (PubMed ID: 33537865)
1. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.
Jin K; Luo J; Yu X; Guo X
Radiat Oncol; 2024 May; 19(1):62. PubMed ID: 38802888
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center.
Díaz-Gavela AA; Cerro Peñalver ED; Sanchez-Garcia S; Pardo-Perez E; Thuissard-Vasallo IJ; Andreu-Vázquez C; Molina López MY; Pena Huertas M; Guerrero-Gómez LL; Sanz-Rosa D; Lorenzo FC
Brachytherapy; 2024; 23(3):342-354. PubMed ID: 38522961
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Radiation Induced Pneumonitis and Pericarditis in Patients Undergoing Breast Conservative Treatment Using Hypofractionated Simultaneous Integrated Boost Technique.
Sundaramoorthy S; Karunanidhi G; Pal P; C SV; Radhakrishnan H
Gulf J Oncolog; 2024 May; 1(45):15-29. PubMed ID: 38774929
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients.
Bao YQ; Yu TH; Huang W; Mao QF; Tu GJ; Li B; Yi A; Li JG; Rao J; Zhang HW; Jiang CL
Breast Cancer; 2024 May; ():. PubMed ID: 38705942
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial.
Yadav BS; Dahiya D; Gupta M; Gupta A; Oinam AS; Khare S; Irrinki S; Robert N; Sakaray YR; Nagaraj SS; Kumari R
Lancet Reg Health Southeast Asia; 2024 May; 24():100392. PubMed ID: 38550605
[TBL] [Abstract][Full Text] [Related]
6. Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results.
Ratosa I; Montero A; Ciervide R; Alvarez B; García-Aranda M; Valero J; Chen-Zhao X; Lopez M; Zucca D; Hernando O; Sánchez E; de la Casa MA; Alonso R; Fernandez-Leton P; Rubio C
Clin Transl Radiat Oncol; 2024 May; 46():100764. PubMed ID: 38516338
[TBL] [Abstract][Full Text] [Related]
7. Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy.
Cicchetti A; Mangili P; Fodor A; Gabellini MGU; Chiara A; Deantoni C; Mori M; Pasetti M; Palazzo G; Rancati T; Del Vecchio A; Gisella Di Muzio N; Fiorino C
Radiother Oncol; 2024 May; 194():110183. PubMed ID: 38423138
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Maraldo MV; Offersen BV
Ugeskr Laeger; 2024 Mar; 186(12):. PubMed ID: 38533873
[TBL] [Abstract][Full Text] [Related]
9. Correction to: A comparative study of boost dose delivery techniques in breast cancer radiotherapy optimising efficacy and minimising toxicity.
Radiat Prot Dosimetry; 2024 Apr; 200(5):524. PubMed ID: 38427457
[No Abstract] [Full Text] [Related]
10. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
[TBL] [Abstract][Full Text] [Related]
11. Comparison of helical and TomoDirect techniques with simultaneous integrated boost in early breast cancer patients.
Onal C; Bozca R; Oymak E; Guler OC
Rep Pract Oncol Radiother; 2023; 28(4):541-550. PubMed ID: 37795226
[TBL] [Abstract][Full Text] [Related]
12. Safety of hypofractionated volumetric modulated arc therapy for early breast cancer: A preliminary report.
Lee JW; Chung MJ
Oncol Lett; 2023 Aug; 26(2):330. PubMed ID: 37415628
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning for Predicting Clinician Evaluation of Treatment Plans for Left-Sided Whole Breast Radiation Therapy.
Fiandra C; Cattani F; Leonardi MC; Comi S; Zara S; Rossi L; Jereczek-Fossa BA; Fariselli P; Ricardi U; Heijmen B
Adv Radiat Oncol; 2023; 8(5):101228. PubMed ID: 37405256
[TBL] [Abstract][Full Text] [Related]
14. Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients.
Dicuonzo S; Leonardi MC; Raimondi S; Corrao G; Bagnardi V; Gerardi MA; Morra A; Zerella MA; Zaffaroni M; Pansini F; Cattani F; Luraschi R; Fodor C; Veronesi P; Orecchia R; Rojas DP; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Jul; 23(7):1415-1428. PubMed ID: 33537865
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series.
Franco P; Zeverino M; Migliaccio F; Sciacero P; Cante D; Casanova Borca V; Torielli P; Arrichiello C; Girelli G; Numico G; La Porta MR; Tofani S; Ricardi U
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1927-36. PubMed ID: 24037488
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated and hypofractionated simultaneous integrated boost adjuvant breast radiation employing statics ports of tomotherapy (TomoDirect): a prospective phase II trial.
Franco P; Zeverino M; Migliaccio F; Cante D; Sciacero P; Casanova Borca V; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
J Cancer Res Clin Oncol; 2014 Jan; 140(1):167-77. PubMed ID: 24292425
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
De Rose F; Fogliata A; Franceschini D; Iftode C; Navarria P; Comito T; Franzese C; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review.
Schmitt M; Menoux I; Chambrelant I; Hild C; Petit T; Mathelin C; Noël G
Transl Oncol; 2022 Aug; 22():101456. PubMed ID: 35609442
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
